Over the past century we have become adept at suppressing the symptoms of respiratory diseases but we have made little progress in curing them. Respiratory diseases are responsible for over 650,000 deaths annually in the EU and the burden on health systems is increasing as the population ages. A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases. All stakeholders in respiratory medicine are pooling their knowledge and resources to focus on risk factors to find cures, formulate new vaccines and develop cutting-edge technologies to tackle the burden of chronic respiratory diseases.
European Respiratory Society: A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases.
Share this post
Latest News posts
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
English prescription charge to rise 1st May 2024
April 26, 2024
The Role of Speech & Language Therapy (SALT)
April 16, 2024
Understanding How Our Lungs Fight Fungus
April 15, 2024
Chronic illness diagnosis and guilt
April 12, 2024
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video